Acute Stroke

Abstract

Stroke remains one of the leading determinants of death and severe disability worldwide. It is a medical emergency with a narrow window for recognition and administration of outcome-modifying treatment in the emergency department. Ischemic stroke accounts for the majority of cerebrovascular events and revascularization therapies such as intravenous thrombolysis and endovascular thrombectomy are the mainstays of treatment in carefully selected patients. Intracerebral hemorrhage is less common but remains the deadliest type of stroke. Blood pressure reduction and hemostatic treatment in case of coagulopathy are the cornerstones of acute intracerebral hemorrhage treatment. Admission to dedicated stroke units is associated with improved outcome in patients suffering from acute stroke.

Keywords

stroke - ischemia - intracerebral hemorrhage - diagnosis - treatment

Disclosures

Andrea Morotti, Loris Poli, and Paolo Costa report no disclosures.

• References

• 1 Hankey GJ. Stroke. Lancet 2017; 389 (10069): 641-654
• 2 Saver JL. Time is brain--quantified. Stroke 2006; 37 (01) 263-266
• 3 Hasan TF, Rabinstein AA, Middlebrooks EH. , et al. Diagnosis and management of acute ischemic stroke. Mayo Clin Proc 2018; 93 (04) 523-538
• 4 Gross H, Grose N. Emergency neurological life support: acute ischemic stroke. Neurocrit Care 2017; 27 (Suppl. 01) 102-115
• 5 Powers WJ, Rabinstein AA, Ackerson T. , et al; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49 (03) e46-e110
• 6 Ekundayo OJ, Saver JL, Fonarow GC. , et al. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2013; 6 (03) 262-269
• 7 Lin CB, Peterson ED, Smith EE. , et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2012; 5 (04) 514-522
• 8 Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol 2017; 16 (03) 227-237
• 9 Lobanova I, Qureshi AI. Blood pressure goals in acute stroke-how low do you go?. Curr Hypertens Rep 2018; 20 (04) 28
• 10 Tsivgoulis G, Zand R, Katsanos AH. , et al. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis. Stroke 2015; 46 (05) 1281-1287
• 11 Liberman AL, Prabhakaran S. Stroke chameleons and stroke mimics in the emergency department. Curr Neurol Neurosci Rep 2017; 17 (02) 15
• 12 Saber Tehrani AS, Kattah JC, Kerber KA. , et al. Diagnosing stroke in acute dizziness and vertigo: pitfalls and pearls. Stroke 2018; 49 (03) 788-795
• 13 Arch AE, Weisman DC, Coca S, Nystrom KV, Wira III CR, Schindler JL. Missed ischemic stroke diagnosis in the emergency department by emergency medicine and neurology services. Stroke 2016; 47 (03) 668-673
• 14 Kamalian S, Lev MH. The adult patient with acute neurologic deficit: an update on imaging trends. Neuroimaging Clin N Am 2018; 28 (03) 319-334
• 15 Rudkin S, Cerejo R, Tayal A, Goldberg MF. Imaging of acute ischemic stroke. Emerg Radiol 2018; 25 (06) 659-672
• 16 Pexman JH, Barber PA, Hill MD. , et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001; 22 (08) 1534-1542
• 17 Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA “dot” sign: a CT marker of acute ischemia. Stroke 2001; 32 (01) 84-88
• 18 Campbell BCV, Parsons MW. Imaging selection for acute stroke intervention. Int J Stroke 2018; 13 (06) 554-567
• 19 Wintermark M, Sanelli PC, Albers GW. , et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol 2013; 34 (11) E117-E127
• 20 Sunshine JL. The great acute-stroke imaging debate–CT, CTA, MR, MRA, perfusion: pros and cons. J Vasc Interv Radiol 2003; 14 (02) 55
• 21 Graham BR, Menon BK, Coutts SB, Goyal M, Demchuk AM. Computed tomographic angiography in stroke and high-risk transient ischemic attack: do not leave the emergency department without it!. Int J Stroke 2018; 13 (07) 673-686
• 22 Al-Ajlan FS, Qazi E, Kim CK, Venkatesan EP, Wilson L, Menon BK. Multimodality CT based imaging to determine clot characteristics and recanalization with intravenous tPA in patients with acute ischemic stroke. Neurovasc Imaging 2017; 3 (01) 2
• 23 Mortimer AM, Little DH, Minhas KS, Walton ER, Renowden SA, Bradley MD. Thrombus length estimation in acute ischemic stroke: a potential role for delayed contrast enhanced CT. J Neurointerv Surg 2014; 6 (03) 244-248
• 24 Bang OY, Goyal M, Liebeskind DS. Collateral circulation in ischemic stroke: assessment tools and therapeutic strategies. Stroke 2015; 46 (11) 3302-3309
• 25 Nguyen-Huynh MN, Wintermark M, English J. , et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease?. Stroke 2008; 39 (04) 1184-1188
• 26 Chaturvedi S, Bhattacharya P. Large artery atherosclerosis: carotid stenosis, vertebral artery disease, and intracranial atherosclerosis. Continuum (Minneap Minn) 2014; 20 (2, Cerebrovascular Disease): 323-334
• 27 Brinjikji W, Demchuk AM, Murad MH. , et al. Neurons over nephrons: systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke. Stroke 2017; 48 (07) 1862-1868
• 28 Bulut HT, Yildirim A, Ekmekci B, Eskut N, Gunbey HP. False-negative diffusion-weighted imaging in acute stroke and its frequency in anterior and posterior circulation ischemia. J Comput Assist Tomogr 2014; 38 (05) 627-633
• 29 Debette S, Compter A, Labeyrie M-A. , et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol 2015; 14 (06) 640-654
• 30 Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11 (10) 906-917
• 31 Singhal AB, Topcuoglu MA, Fok JW. , et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. Ann Neurol 2016; 79 (06) 882-894
• 32 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14 (09) 914-925
• 33 Salvarani C, Brown Jr RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet 2012; 380 (9843): 767-777
• 34 Etherton MR, Barreto AD, Schwamm LH, Wu O. Neuroimaging paradigms to identify patients for reperfusion therapy in stroke of unknown onset. Front Neurol 2018; 9: 327
• 35 Schwamm LH, Wu O, Song SS. , et al; MR WITNESS Investigators. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results. Ann Neurol 2018; 83 (05) 980-993
• 36 Menon BK, Goyal M. Imaging paradigms in acute ischemic stroke: a pragmatic evidence-based approach. Radiology 2015; 277 (01) 7-12
• 37 Wardlaw J, Brazzelli M, Miranda H. , et al. An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation. Health Technol Assess 2014; 18 (27) 1-368 , v–vi
• 38 Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56 (08) 1015-1020
• 39 Wouters A, Lemmens R, Dupont P, Thijs V. Wake-up stroke and stroke of unknown onset: a critical review. Front Neurol 2014; 5: 153
• 40 Wu O, Schwamm LH, Sorensen AG. Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am 2011; 21 (02) 327-344 , xi
• 41 Campbell BCV, Weir L, Desmond PM. , et al. CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2013; 84 (06) 613-618
• 42 Emberson J, Lees KR, Lyden P. , et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384 (9958): 1929-1935
• 43 Thomalla G, Simonsen CZ, Boutitie F. , et al; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018; 379 (07) 611-622
• 44 Anderson CS, Robinson T, Lindley RI. , et al; ENCHANTED Investigators and Coordinators. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 2016; 374 (24) 2313-2323
• 45 Goldstein JN, Marrero M, Masrur S. , et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol 2010; 67 (08) 965-969
• 46 Chang A, Llinas EJ, Chen K, Llinas RH, Marsh EB. Shorter intensive care unit stays? The majority of post-intravenous tPA (tissue-type plasminogen activator) symptomatic hemorrhages occur within 12 hours of treatment. Stroke 2018; 49 (06) 1521-1524
• 47 Yaghi S, Willey JZ, Cucchiara B. , et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48 (12) e343-e361
• 48 Myslimi F, Caparros F, Dequatre-Ponchelle N. , et al. Orolingual angioedema during or after thrombolysis for cerebral ischemia. Stroke 2016; 47 (07) 1825-1830
• 49 Bivard A, Huang X, Levi CR. , et al. Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology 2017; 89 (01) 62-67
• 50 Campbell BCV, Mitchell PJ, Churilov L. , et al; EXTEND-IA TNK Investigators. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018; 378 (17) 1573-1582
• 51 Berkhemer OA, Fransen PSS, Beumer D. , et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (01) 11-20
• 52 Goyal M, Demchuk AM, Menon BK. , et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372 (11) 1019-1030
• 53 Saver JL, Goyal M, Bonafe A. , et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372 (24) 2285-2295
• 54 Jovin TG, Chamorro A, Cobo E. , et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372 (24) 2296-2306
• 55 Campbell BCV, Mitchell PJ, Kleinig TJ. , et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372 (11) 1009-1018
• 56 Nogueira RG, Jadhav AP, Haussen DC. , et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378 (01) 11-21
• 57 Albers GW, Marks MP, Kemp S. , et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378 (08) 708-718
• 58 Kernan WN, Ovbiagele B, Black HR. , et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45 (07) 2160-2236
• 59 Noiphithak R, Liengudom A. Recent update on carotid endarterectomy versus carotid artery stenting. Cerebrovasc Dis 2017; 43 (1–2): 68-75
• 60 Neugebauer H, Woitzik J. Decompressive craniectomy in malignant middle cerebral artery infarction: to be, or not to be?. Neurol Clin Pract 2016; 6 (05) 381-383
• 61 Jüttler E, Unterberg A, Woitzik J. , et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 2014; 370 (12) 1091-1100
• 62 Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373 (9675): 1632-1644
• 63 Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am 2016; 34 (04) 883-899
• 64 Macellari F, Paciaroni M, Agnelli G, Caso V. Neuroimaging in intracerebral hemorrhage. Stroke 2014; 45 (03) 903-908
• 65 Hemphill III JC, Greenberg SM, Anderson CS. , et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (07) 2032-2060
• 66 Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 2013; 35 (03) 195-201
• 67 Morotti A, Dowlatshahi D, Boulouis G. , et al; ATACH-II, NETT, and PREDICT Investigators. Predicting intracerebral hemorrhage expansion with noncontrast computed tomography: the BAT Score. Stroke 2018; 49 (05) 1163-1169
• 68 Morotti A, Goldstein JN. New oral anticoagulants and their reversal agents. Curr Treat Options Neurol 2016; 18 (11) 47
• 69 Veltkamp R, Horstmann S. Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view. Clin Lab Med 2014; 34 (03) 587-594
• 70 Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32 (04) 891-897
• 71 Morotti A, Boulouis G, Romero JM. , et al; ATACH-II and NETT investigators. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology 2017; 89 (06) 548-554
• 72 Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN. Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke 2017; 48 (04) 1120-1125
• 73 Khosravani H, Mayer SA, Demchuk A. , et al. Emergency noninvasive angiography for acute intracerebral hemorrhage. AJNR Am J Neuroradiol 2013; 34 (08) 1481-1487
• 74 Hilkens NA, van Asch CJJ, Werring DJ. , et al; DIAGRAM study group. Predicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction score. J Neurol Neurosurg Psychiatry 2018; 89 (07) 674-679
• 75 Morotti A, Brouwers HB, Romero JM. , et al; Antihypertensive Treatment of Acute Cerebral Hemorrhage II and Neurological Emergencies Treatment Trials Investigators. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol 2017; 74 (08) 950-960
• 76 Goldstein JN, Fazen LE, Snider R. , et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 2007; 68 (12) 889-894
• 77 Demchuk AM, Dowlatshahi D, Rodriguez-Luna D. , et al; PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012; 11 (04) 307-314
• 78 Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003; 227 (02) 522-528
• 79 Anderson CS, Heeley E, Huang Y. , et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368 (25) 2355-2365
• 80 Qureshi AI, Palesch YY, Barsan WG. , et al; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016; 375 (11) 1033-1043
• 81 Whelton PK, Carey RM, Aronow WS. , et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2018; 71 (19) e127-e248
• 82 Andrews CM, Jauch EC, Hemphill III JC, Smith WS, Weingart SD. Emergency neurological life support: intracerebral hemorrhage. Neurocrit Care 2012; 17 (Suppl. 01) S37-S46
• 83 Baharoglu MI, Cordonnier C, Al-Shahi Salman R. , et al; PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016; 387 (10038): 2605-2613
• 84 Frontera JA, Lewin III JJ, Rabinstein AA. , et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care 2016; 24 (01) 6-46
• 85 Siegal DM, Curnutte JT, Connolly SJ. , et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015; 373 (25) 2413-2424
• 86 Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164 (08) 880-884
• 87 Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63 (06) 1059-1064
• 88 Steiner T, Poli S, Griebe M. , et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol 2016; 15 (06) 566-573
• 89 Pollack Jr CV, Reilly PA, van Ryn J. , et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med 2017; 377 (05) 431-441
• 90 Heidbuchel H, Verhamme P, Alings M. , et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015; 17 (10) 1467-1507
• 91 Steiner T, Weitz JI, Veltkamp R. Anticoagulant-associated intracranial hemorrhage in the era of reversal agents. Stroke 2017; 48 (05) 1432-1437
• 92 Mendelow AD, Gregson BA, Fernandes HM. , et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365 (9457): 387-397
• 93 Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. ; STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382 (9890): 397-408
• 94 Beynon C, Schiebel P, Bösel J, Unterberg AW, Orakcioglu B. Minimally invasive endoscopic surgery for treatment of spontaneous intracerebral haematomas. Neurosurg Rev 2015; 38 (03) 421-428 , discussion 428